Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cellular Immunology
|
September 9, 2022
Restoring tolerance to β-cells in Type 1 diabetes: Current and emerging strategies
Kaitlin R Carroll, Jonathan D Katz
Seminars in Immunology
|
August 16, 2025
Diffuse neuropsychiatric lupus: Clinical evidence, immune-mediated mechanisms, and therapeutic insights
Rachel Weissman-Tsukamoto, Kaitlin R Carroll, Betty Diamond
Current Rheumatology Reports
|
March 30, 2021
Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches
Aida Zarfeshani, Kaitlin R Carroll, Bruce T Volpe, et al.
Journal of Autoimmunity
|
September 20, 2022
Cognitive dysfunction in SLE: An understudied clinical manifestation
Mark Mizrachi, Erik Anderson, Kaitlin R Carroll, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
Long-term Tolerance to Islet Transplantation via Targeted Reduction of beta cell-specific T cells
Michael Kotliar, Eileen E Cianciolo, Duc Hung Pham, et al.
Diabetes
|
August 15, 2018
Extending Remission and Reversing New-Onset Type 1 Diabetes by Targeted Ablation of Autoreactive T Cells
Kaitlin R Carroll, Eileen E Elfers, Joseph J Stevens, et al.
Research Square
|
June 9, 2023
Lupus autoantibodies initiate a maladaptive equilibrium sustained by HMGB1:RAGE signaling and reversed by LAIR-1:C1q signaling
Kaitlin R Carroll, Mark Mizrachi, Sean Simmons, et al.
Nature Immunology
|
December 19, 2019
T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity
Aakanksha Jain, Ricardo A Irizarry-Caro, Margaret M McDaniel, et al.
Nature Immunology
|
March 6, 2024
Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression
Kaitlin R Carroll, Mark Mizrachi, Sean Simmons, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Jonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cellular Immunology
|
September 9, 2022
Restoring tolerance to β-cells in Type 1 diabetes: Current and emerging strategies
Kaitlin R Carroll, Jonathan D Katz
Seminars in Immunology
|
August 16, 2025
Diffuse neuropsychiatric lupus: Clinical evidence, immune-mediated mechanisms, and therapeutic insights
Rachel Weissman-Tsukamoto, Kaitlin R Carroll, Betty Diamond
Current Rheumatology Reports
|
March 30, 2021
Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches
Aida Zarfeshani, Kaitlin R Carroll, Bruce T Volpe, et al.
Journal of Autoimmunity
|
September 20, 2022
Cognitive dysfunction in SLE: An understudied clinical manifestation
Mark Mizrachi, Erik Anderson, Kaitlin R Carroll, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
Long-term Tolerance to Islet Transplantation via Targeted Reduction of beta cell-specific T cells
Michael Kotliar, Eileen E Cianciolo, Duc Hung Pham, et al.
Diabetes
|
August 15, 2018
Extending Remission and Reversing New-Onset Type 1 Diabetes by Targeted Ablation of Autoreactive T Cells
Kaitlin R Carroll, Eileen E Elfers, Joseph J Stevens, et al.
Research Square
|
June 9, 2023
Lupus autoantibodies initiate a maladaptive equilibrium sustained by HMGB1:RAGE signaling and reversed by LAIR-1:C1q signaling
Kaitlin R Carroll, Mark Mizrachi, Sean Simmons, et al.
Nature Immunology
|
December 19, 2019
T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity
Aakanksha Jain, Ricardo A Irizarry-Caro, Margaret M McDaniel, et al.
Nature Immunology
|
March 6, 2024
Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression
Kaitlin R Carroll, Mark Mizrachi, Sean Simmons, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Jonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Page
of 1